1 Min Read
March 23 (Reuters) - Lupin Ltd:
* Says lupin receives FDA approval for generic Tobi® inhalation solution
* Says drug is indicated for the management of cystic fibrosis patients with P. Aeruginosa Source text: bit.ly/2nM6ib1 Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.